OEM Canine Parvovirus Detection – COVID-19 Detection reagent equipment – CILIANG
OEM Canine Parvovirus Detection – COVID-19 Detection reagent equipment – CILIANG Detail:
Neutralizing antibody against SARS-CoV-2 can resist human immune SARS-CoV-2 infection.
Therefore, the detection of neutralizing antibodies against SARS-CoV-2 has important clinical significance for patients with convalescent infection or for vaccination of SARS-CoV-2 vaccine.
The SARS-CoV-2 Neutralizing Antibody Test Kit is for the qualitative detection of neutralizing antibodies to SARS-CoV-2 in human serum, plasma or whole blood sample. The test kit is intended for use outside the body only (in vitro diagnostic use) for professional use and should not be used to diagnose acute SARS-CoV-2 infection.
Analyzer
Test Kit
Product
Method
Specimen type
Specimen volume
Test time
Package size
Storage
SARS-CoV-2 Neutralizing Antibody Test Kit
Fluorescence Immunochromatography
Serum, plasma or whole blood sample
25µl
10 minutes
25 pcs/box; 50 pcs/box
4℃~30℃
Product detail pictures:
Related Product Guide:
We emphasize progress and introduce new merchandise into the market each and every year for OEM Canine Parvovirus Detection – COVID-19 Detection reagent equipment – CILIANG, The product will supply to all over the world, such as: Dubai, Brazil, Turkey, By integrating manufacturing with foreign trade sectors, we can provide total customer solutions by guaranteeing the delivery of right products to the right place at the right time, which is supported by our abundant experiences, powerful production capability, consistent quality, diversified product portfolios and the control of the industry trend as well as our mature before and after sales services. We'd like to share our ideas with you and welcome your comments and questions.
By Sara from Benin - 2017.08.18 18:38
The company has rich resources, advanced machinery, experienced workers and excellent services, hope you keep improving and perfecting your products and service, wish you better!
By Arlene from Rome - 2018.06.18 19:26
